✦ LIBER ✦

Odanacatib in the treatment of postmenopausal women with low bone mineral density: 3-year continued therapy and resolution of effect

✍ Scribed by D. Hosking⁎; J.A. Eisman; H. Bone; M. McClung; I. Reid; R. Rizzoli; H. Resch; N. Verbruggen; C. Hustad; A. Santora; A. Lombardi

Book ID: 116323058
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 57 KB
Volume: 47
Category: Article
ISSN: 8756-3282
DOI: 10.1016/j.bone.2010.04.132

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Odanacatib in the Treatment of Postmenop

Odanacatib in the Treatment of Postmenopausal Women with Low Bone Mineral Density: 3-Year Continued Therapy and Resolution of Effect

✍ Ian Reid; John Eisman; Henry Bone; David Hosking; Michael McClung; Rene Rizzoli; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Odanacatib in the Treatment of Postmenop

Odanacatib in the Treatment of Postmenopausal Women with Low Bone Mineral Density: 3-Year Continued Therapy and Resolution of Effect

✍ McClung, Michael R.; Eisman, John A.; Bone, Henry G.; Hosking, David J.; Reid, I 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 115 KB

Odanacatib in the treatment of postmenop

Odanacatib in the treatment of postmenopausal women with low bone mineral density: Three-year continued therapy and resolution of effect

✍ John A Eisman; Henry G Bone; David J Hosking; Michael R McClung; Ian R Reid; Ren 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 211 KB 👁 2 views

## Abstract The selective cathepsin K inhibitor odanacatib (ODN) progressively increased bone mineral density (BMD) and decreased bone‐resorption markers during 2 years of treatment in postmenopausal women with low BMD. A 1‐year extension study further assessed ODN efficacy and safety and the effec

Odanacatib in the treatment of postmenop

Odanacatib in the treatment of postmenopausal women with low bone mineral density: Five years of continued therapy in a phase 2 study

✍ Langdahl, Bente; Binkley, Neil; Bone, Henry; Gilchrist, Nigel; Resch, Heinrich; 📂 Article 📅 2012 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 133 KB

Two-Year Results of Odanacatib (MK-822)

Two-Year Results of Odanacatib (MK-822) Treatment in Postmenopausal Women with Low Bone Mineral Density

✍ McClung, Michael; Eisman, John; Bone, Henry; Roux, Christian; Recker, Robert; Ve 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Four-year results of a phase 2 study of

Four-year results of a phase 2 study of the cathepsin K inhibitor odanacatib in postmenopausal women with low bone mineral density: Effects on bone mineral density and bone turnover markers

✍ H. Resch; N. Binkley; H. Bone; J. Eisman; D. Hosking; B. Langdahl; M. McClung; I 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 61 KB